Easton Pharmaceuticals Inc. a Canadian pharmaceutical company has just announced that it has been selected to take part in the acquisition of the Greek casino complex: Club Hotel Casino Loutraki . This is certainly a follow-up to the announcement made earlier this year that the pharmaceutical company will show interest in casinos.
The emblem of land gambling in Greece
Loutraki is one of the best casino complexes in southern European countries. Quality services and diversified activities have built its reputation. The casino has 225 rooms and 20 suites. A ith this, a wellness center and spa with conference rooms and most important is that the property is composed of hundreds of slot machines with 87 gaming tables . A VIP area is of course available in the building. The casino is a real tourist icon, being located just 80 kilometers from the capital, many international players have already made their way into the casino.
A continuation of the projects of the CEO of Easton
Since the 90s, the CEO of Easton has already privatized many companies operating in the games and casinos. According to him, he currently wants to explore new lands by interfering in the Greek gaming industry. However, the purchase price has not yet been indicated. Apart from this project in Greece, Easton also intends to participate in a project to expand a hotel complex and casinos project in Europe. This next project still remains anonymous, however, the pharmaceutical company is thinking of cooperating with a large American company. The casino will potentially include 1,000 slot machines with 50 gaming tables with a hotel consisting of 384 rooms. The projects of the pharmaceutical company therefore promise to be fully ambitious.